We follow the science to solve the human body’s most complex mysteries. From our rapid response efforts to infectious diseases to the complex world of oncology, we’ve invented new technologies and pioneered novel approaches to revolutionize how to make medicine.
Following the science leads to unexpected breakthroughs and diverse areas of study — from ophthalmology to cancer to inflammation to pain to cardiovascular disease.Our therapeutic
Our scientists are leading the way, developing new technologies to
help discover better and novel antibodies. Discover the past, present
and future of antibody medicine.
In my twenty years at Regeneron, I have been lucky to be a part of discovering exciting new antibody drugs and have seen many of them make it across the approval “finish line” where they can be given to patients in need.
Drew Murphy, PhD
Executive Vice President of Research
how to make
Our proprietary VelociSuite® technologies improve and accelerate the way medicines are traditionally discovered and developed.
We’ve raised the bar for R&D excellence and productivity in biotech.
See how we’ve applied our technologies and novel approaches for good in response to public health crises like the Ebola epidemic and COVID-19 pandemic.
Transparency is a hallmark of scientific progress. Our pioneering scientists regularly publish their research in leading scientific journals, including 175+ peer-reviewed publications in 2020.OUR LIBRARY OF PUBLICATIONS
the next million
The Regeneron Genetics Center® is creating the world's most comprehensive genotype-phenotype database, enabling deeper understanding of the genetic factors that cause or influence a range of human diseases.LEARN ABOUT THE RGC